Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FW542
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,962
Award facts
- Contract value 100% obligated
- $26,961.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $27,000 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is executed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, serving as the operational hub for pharmaceutical distribution and healthcare solutions to federal military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $1 billion IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and enables the company to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds the parent IDC authority. The delivery order award demonstrates the company's established capability to meet federal procurement requirements through open competition and reflects DLA's ongoing reliance on AmerisourceBergen as a prime pharmaceutical vendor for global defense health operations.
Quick answers
Who was awarded contract SPE2DU26FW542?
SPE2DU26FW542 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DU26FW542 worth?
The government has obligated $26,962 on SPE2DU26FW542.
Is contract SPE2DU26FW542 an order under another contract?
Yes. SPE2DU26FW542 is a delivery order under SPE2DU25D4319, an indefinite delivery contract.
Was contract SPE2DU26FW542 competed?
The extent of competition for SPE2DU26FW542 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award